ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IRGI Inveresk Research Grp. (MM)

0.00
0.00 (0.00%)
Pre Market
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Inveresk Research Grp. (MM) NASDAQ:IRGI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Inveresk Research Announces Fourth Quarter and Full Year 2003 Earnings Release and Webcast

08/01/2004 5:07pm

PR Newswire (US)


Inveresk (NASDAQ:IRGI)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Inveresk Charts.
Inveresk Research Announces Fourth Quarter and Full Year 2003 Earnings Release and Webcast Conference Call on Tuesday, February 3, 2004 at 10:00 a.m. EST CARY, N.C., Jan. 8 /PRNewswire-FirstCall/ -- Inveresk Research Group, Inc. will be announcing its fourth quarter and full year earnings results for the fiscal year ended December 31, 2003, after the market closes on Monday, February 2, 2004. Management of the company will host a conference call to discuss these results on Tuesday, February 3, 2004, at 10:00 a.m. Eastern Standard Time. Presenting from the company will be Walter Nimmo, President and Chief Executive Officer and Paul Cowan, Chief Financial Officer. The conference call will be webcast live and will also be available for replay two hours after the completion of the call until 5:00 pm EST on Tuesday, February 10, 2004. To access the webcast, visit the Company's web site at http://www.inveresk.com/. Inveresk Research is a leading provider of drug development services to companies in the pharmaceutical and biotechnology industries. Through its pre-clinical and clinical business segments, the Company offers a broad range of drug development services, including pre-clinical safety and pharmacology evaluation services, laboratory sciences services and clinical development services. Inveresk Research is one of a small number of drug development services companies currently providing a comprehensive range of pre-clinical and clinical development services on a worldwide basis. The Company's client base includes major pharmaceutical companies in North America, Europe and Japan, as well as many biotechnology and specialty pharmaceutical companies. For more information on Inveresk Research, visit the Company's web site at http://www.inveresk.com/. DATASOURCE: Inveresk Research Group, Inc. CONTACT: Matt Dallas of Financial Dynamics, +1-212-850-5627, , for Inveresk Research Group, Inc. Web site: http://www.inveresk.com/

Copyright

1 Year Inveresk Chart

1 Year Inveresk Chart

1 Month Inveresk Chart

1 Month Inveresk Chart

Your Recent History

Delayed Upgrade Clock